Funding
Funding not disclosed
Founders
Product
Problem
Many organizations lack a clear framework to assess their exposure to quantum computing and post‑quantum cryptography risks, resulting in undefined roadmaps, unverified vendor claims, and regulatory non‑compliance. The absence of standardized scoring and deployment infrastructure makes it difficult to translate quantum capabilities into actionable business solutions.
Solution
DeployQuantum offers a unified platform that guides enterprises through quantum readiness. The platform provides free educational resources, a product‑grade simulation engine for fixed‑scope proofs of concept, and repeatable, standalone solutions that can be purchased and deployed directly. By combining a data‑driven assessment engine, custom quantum roadmaps, and fractional quantum leadership, DeployQuantum enables organizations to measure their quantum exposure, evaluate vendors, and implement quantum‑ready solutions on a predictable timeline and price.
Target Audience
Primary customers are mid‑size to large enterprises in regulated sectors (finance, critical infrastructure, pharmaceuticals) that need to demonstrate quantum‑readiness, as well as investment firms and board members requiring clear quantum risk assessments.
Features
- Free, continuously expanding learning hub covering NIST PQC standards and regulatory requirements
- Product‑grade quantum simulation engine that delivers working proofs of concept within a defined scope and fixed timeline
- Custom quantum roadmaps that map current state, identify use cases, and outline phased adoption plans with cost and resource estimates
- Fractional Chief Quantum Officer service providing strategic direction, vendor evaluation, and team coordination without a full‑time hire
- Quantum due‑diligence assessments that evaluate vendor claims, IP position, and technical feasibility
- Industry‑specific QR8 and PQC assessment scans tailored to regulatory environments and threat models
- PoC‑in‑a‑Box templates for portfolio optimization, logistics, drug discovery, and financial risk, delivered in 14 days
- Fixed‑price, fixed‑scope engagement model with a three‑step workflow: discovery call, scoped proposal within 48 hours, and delivery on agreed timeline